Technical Analysis for 0O5H - Elekta AB ser. B
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 80.10 | 0.00% | 0.00 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Flat | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Fell Below 200 DMA | Bearish | 0.00% |
Free Daily (Stock) Chart Reading
Elekta AB ser. B Description
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Classification
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 89.22 |
52 Week Low | 72.42 |
Average Volume | 69,927 |
200-Day Moving Average | 80.24 |
50-Day Moving Average | 77.69 |
20-Day Moving Average | 78.31 |
10-Day Moving Average | 79.78 |
Average True Range | 7.57 |
RSI (14) | 57.08 |
ADX | 37.91 |
+DI | 5.08 |
-DI | 2.81 |
Chandelier Exit (Long, 3 ATRs) | 65.15 |
Chandelier Exit (Short, 3 ATRs) | 95.12 |
Upper Bollinger Bands | 81.78 |
Lower Bollinger Band | 74.84 |
Percent B (%b) | 0.76 |
BandWidth | 8.86 |
MACD Line | 0.87 |
MACD Signal Line | 0.58 |
MACD Histogram | 0.2879 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 91.62 | ||||
Resistance 3 (R3) | 90.34 | 85.22 | 89.70 | ||
Resistance 2 (R2) | 85.22 | 82.29 | 85.86 | 89.06 | |
Resistance 1 (R1) | 82.66 | 80.47 | 83.94 | 83.94 | 88.42 |
Pivot Point | 77.54 | 77.54 | 78.18 | 78.18 | 77.54 |
Support 1 (S1) | 74.98 | 74.61 | 76.26 | 76.26 | 71.78 |
Support 2 (S2) | 69.86 | 72.79 | 70.50 | 71.14 | |
Support 3 (S3) | 67.30 | 69.86 | 70.50 | ||
Support 4 (S4) | 68.58 |